Advertisement
Advertisement
U.S. Markets open in 3 hrs 52 mins
Advertisement
Advertisement
Advertisement
Advertisement

CVS Health Corporation (CVS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
95.34+2.61 (+2.81%)
At close: 4:00PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/29/2021
Current
Market Cap (intraday) 5
N/A
Enterprise Value 3
N/A
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 7
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.80
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 396.57
52 Week Low 367.06
50-Day Moving Average 388.40
200-Day Moving Average 382.37

Share Statistics

Avg Vol (3 month) 35.39M
Avg Vol (10 day) 35.17M
Shares Outstanding 51.32B
Implied Shares Outstanding 6N/A
Float 81.32B
% Held by Insiders 10.17%
% Held by Institutions 178.86%
Shares Short (Sep 14, 2021) 414.82M
Short Ratio (Sep 14, 2021) 43.07
Short % of Float (Sep 14, 2021) 41.13%
Short % of Shares Outstanding (Sep 14, 2021) 41.12%
Shares Short (prior month Aug 12, 2021) 415.85M

Dividends & Splits

Forward Annual Dividend Rate 42
Forward Annual Dividend Yield 42.41%
Trailing Annual Dividend Rate 32.00
Trailing Annual Dividend Yield 32.16%
5 Year Average Dividend Yield 42.85
Payout Ratio 436.63%
Dividend Date 3Oct 31, 2021
Ex-Dividend Date 4Oct 20, 2021
Last Split Factor 22:1
Last Split Date 3Jun 06, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 2.60%
Operating Margin (ttm)4.73%

Management Effectiveness

Return on Assets (ttm)3.52%
Return on Equity (ttm)10.17%

Income Statement

Revenue (ttm)277.29B
Revenue Per Share (ttm)211.10
Quarterly Revenue Growth (yoy)11.00%
Gross Profit (ttm)48.25B
EBITDA 17.64B
Net Income Avi to Common (ttm)7.21B
Diluted EPS (ttm)5.61
Quarterly Earnings Growth (yoy)-6.50%

Balance Sheet

Total Cash (mrq)10.12B
Total Cash Per Share (mrq)7.67
Total Debt (mrq)79.65B
Total Debt/Equity (mrq)108.28
Current Ratio (mrq)0.95
Book Value Per Share (mrq)53.96

Cash Flow Statement

Operating Cash Flow (ttm)14.18B
Levered Free Cash Flow (ttm)11.25B
Advertisement
Advertisement